Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Flavia Marturana"'
Autor:
Michael R. Doran B.Sc., B.Eng., Ph.D., Ian Alexander Aird, Flavia Marturana, Nicholas Timmins, Kerry Atkinson, Lars K. Nielsen
Publikováno v:
Cell Transplantation, Vol 21 (2012)
The feasibility of ex vivo blood production is limited by both biological and engineering challenges. From an engineering perspective, these challenges include the significant volumes required to generate even a single unit of a blood product, as wel
Externí odkaz:
https://doaj.org/article/396211a8c8ee4b259e7b7d1ae46cf125
Autor:
Nicholas E. Timmins, Lars K. Nielsen, Ian Alexander Aird, Michael R. Doran, Flavia Marturana, Kerry Atkinson
Publikováno v:
Cell Transplantation, Vol 21 (2012)
Cell Transplantation
Cell Transplantation
The feasibility of ex vivo blood production is limited by both biological and engineering challenges. From an engineering perspective, these challenges include the significant volumes required to generate even a single unit of a blood product, as wel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1244d19704bb4a9df183226cc09edb
https://doi.org/10.3727/096368911x627363
https://doi.org/10.3727/096368911x627363
Publikováno v:
Cytotherapy. 13:366-377
Background aims Despite the availability of modern antibiotics/antimycotics and cytokine support, neutropenic infection accounts for the majority of chemotherapy-associated deaths. While transfusion support with donor neutrophils is possible, cost an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e612e3216500c5e37c63c691423f5fd9
https://doi.org/10.3109/14653249.2010.518610
https://doi.org/10.3109/14653249.2010.518610
Autor:
Gianluca Sbardella, Silvio Massa, Paolo La Colla, Giovanni Maga, Flavia Marturana, Antonello Mai, Massimo Mura, Chiara Musiu, Rino Ragno, Marino Artico, Alessandra Cadeddu
Publikováno v:
Bioorganic & Medicinal Chemistry. 13:2065-2077
2-Alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones (F(2)-NH-DABOs) 4, 5 belonging to the dihydro-alkoxy-benzyl-oxopyrimidine (DABO) family and bearing different alkyl- and arylamino side chains at the C(2)-position o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79bf789573860b68f6083d57bcd25c8f
https://doi.org/10.1016/j.bmc.2005.01.005
https://doi.org/10.1016/j.bmc.2005.01.005
Autor:
Silvio Massa, and Alessandra Cadeddu, M. Mura, Antonello Mai, Flavia Marturana, Rino Ragno, Paolo La Colla, Marino Artico, Gianluca Sbardella, Musiu C
Publikováno v:
Journal of Medicinal Chemistry. 47:928-934
Dihydro-alkoxy-benzyl-oxopyrimidines (DABOs) are a family of potent NNRTIs developed in the past decade. Attempts to improve their potency and selectivity led to thio-DABOs (S-DABOs), DATNOs, and difluoro-thio-DABOs (F(2)-S-DABOs). More recently, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f44f4ba0c8de180bf1881faeab0eb16
https://doi.org/10.1021/jm0309856
https://doi.org/10.1021/jm0309856
Autor:
Kum Kum Khanna, Flavia Marturana, Georgia Chenevix-Trench, Jodi M. Saunus, Gianluca Sala, Leonard Da Silva, Dihua Yu, Amy E. McCart Reed, Peter T. Simpson, Majid Momeny, Sunil R. Lakhani, Stefano Iacobelli, Jane D. Holland, Debra Black
Publikováno v:
Oncotarget
HER2-positive breast tumors are associated with a high risk of brain relapse. HER3 is thought to be an indispensible signaling substrate for HER2 (encoded by ERBB2) and is induced in breast cancer-brain metastases, though the molecular mechanisms by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7196f82191a5eae53b63f56271f86a3c
https://pubmed.ncbi.nlm.nih.gov/25668816
https://pubmed.ncbi.nlm.nih.gov/25668816
Autor:
Nicholas E. Timmins, Flavia Marturana, Sanna Luikenga, Lars K. Nielsen, Genghis H. Lopez, Stefanie Dietmair, Emma Louise Palfreyman, Yoke Lin Fung, R. M. Minchinton
Publikováno v:
Biotechnology and Bioengineering.
Dose-intensive chemotherapy results in an obligatory period of severe neutropenia during which patients are at high risk of infection. While patient support with donor neutrophils is possible, this option is restricted due to donor availability and l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fcc5e35a54d37d90d9a5e94f28e5114
https://doi.org/10.1002/bit.22433
https://doi.org/10.1002/bit.22433